Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Ophthalmol. 2016 Sep 20;172:104–110. doi: 10.1016/j.ajo.2016.09.017

Figure 3.

Figure 3

Scleral photographs of patient 8. Scleral photographs of the temporal right eye were taken after administration of topical phenylephrine 10% at the indicated times in the study. Week 40 is four weeks following the last gevokizumab injection of the first extension phase. Week 52A represents the enrollment date of the second extension phase, which in this patient occurred 7.5 months after her last gevokizumab injection as part of the first extension phase. Week 62 represents the last time point for gevokizumab injection after receiving three injections at weeks 52A, 54, and 58.